Noninvasive ventilation modes and high-flow nasal oxygen in acute and chronic respiratory failure: indications and outcomes

Case-based session
Chairs: A. Simonds (London, United Kingdom), P. Wijkstra (Groningen, Netherlands)
Aims: To provide audience with an understanding of when and how to use different NIV modes and high flow nasal cannulae therapy

Introduction A. Simonds (London, United Kingdom), P. Wijkstra (Groningen, Netherlands)
High-flow nasal cannulae therapy or NIV in patients with exacerbations of chronic obstructive pulmonary disease? L. Pisani (Bologna (BO), Italy)
Continuous positive airway pressure or NIV in patients with acute and chronic obesity hypoventilation syndrome? J. Masa Jiménez (Cáceres, Spain)
Continuous positive airway pressure, oxygen therapy or high-flow nasal oxygen therapy in patients with acute COVID-19 lung disease? A. Simonds (London, United Kingdom)
Overview of the role of high-flow nasal oxygen therapy in acute and chronic respiratory care: has it found its place versus NIV? S. Nava (Bologna (BO), Italy)
Participant case: “Biphasic” COVID-19 complicated with pneumothorax/subcutaneous emphysema S. Sahin Duyar (Ankara, Turkey)
Participant case: Non-invasive ventilation in an asymptomatic infant with hypoventilation S. Warraich (Cambridge, United Kingdom)
Discussion and Q&A L. Pisani (Bologna (BO), Italy), J. Masa Jiménez (Cáceres, Spain), A. Simonds (London, United Kingdom), S. Nava (Bologna (BO), Italy), P. Wijkstra (Groningen, Netherlands), S. Warraich (Cambridge, United Kingdom), S. Sahin Duyar (Ankara, Turkey)